Evidence map›Paper›PMID 32025743›Full record

ArticleCellular and molecular life sciences : CMLS2020

Misfolded amyloid-β-42 impairs the endosomal-lysosomal pathway.

Karen E Marshall, Devkee M Vadukul, Kevin Staras, Louise C Serpell

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Toxic mechanisms of amyloid oligomers and therapeutic strategies.Protein science : a publication of the Protein Society · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. AβJournal of nanobiotechnology · 2024
    Article
  17. Review
  18. Review
  19. Article
  20. Therapeutic effects of a novel synthetic α-secretase.Frontiers in aging neuroscience · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karen E MarshallSussex Neuroscience, School of Life Sciences, University of Sussex, Falmer, BN1 9QG, UK.
Devkee M VadukulSussex Neuroscience, School of Life Sciences, University of Sussex, Falmer, BN1 9QG, UK.
Kevin StarasSussex Neuroscience, School of Life Sciences, University of Sussex, Falmer, BN1 9QG, UK. K.Staras@sussex.ac.uk.
Louise C SerpellSussex Neuroscience, School of Life Sciences, University of Sussex, Falmer, BN1 9QG, UK. L.C.Serpell@sussex.ac.uk.ORCID http://orcid.org/0000-0001-9335-7751
University of Sussex · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K019015/1Medical Research Council MR/K022105/1MRF_ MR/K022105/1
6 · The paper itself

Abstract

Misfolding and aggregation of proteins is strongly linked to several neurodegenerative diseases, but how such species bring about their cytotoxic actions remains poorly understood. Here we used specifically-designed optical reporter probes and live fluorescence imaging in primary hippocampal neurons to characterise the mechanism by which prefibrillar, oligomeric forms of the Alzheimer's-associated peptide, Aβ42, exert their detrimental effects. We used a pH-sensitive reporter, Aβ42-CypHer, to track Aβ internalisation in real-time, demonstrating that oligomers are rapidly taken up into cells in a dynamin-dependent manner, and trafficked via the endo-lysosomal pathway resulting in accumulation in lysosomes. In contrast, a non-assembling variant of Aβ42 (vAβ42) assayed in the same way is not internalised. Tracking ovalbumin uptake into cells using CypHer or Alexa Fluor tags shows that preincubation with Aβ42 disrupts protein uptake. Our results identify a potential mechanism by which amyloidogenic aggregates impair cellular function through disruption of the endosomal-lysosomal pathway.

Indexed as

Protein FoldingAmyloid beta-PeptidesAnimalsCells, CulturedDynaminsEndocytosisEndosomesHydrogen-Ion ConcentrationLysosomesNeuronsOvalbuminPeptide FragmentsRatsAmyloid beta-Peptidesamyloid beta-protein (1-42)DynaminsOvalbuminPeptide FragmentsAmyloid-betaEndocytosisLysosomesOligomerSelf-assemblyToxicity

Identifiers

PMID32025743
PMCPMC7658065
OpenAlexW3005504058

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.